Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$161,061 Mln
P/E Ratio
24.88
P/B Ratio
3.24
Industry P/E
87.38
Debt to Equity
0
ROE
0.14 %
ROCE
7.8 %
Div. Yield
0.41 %
Book Value
130.57
EPS
17.04
CFO
$57,505.80 Mln
EBITDA
$71,539.20 Mln
Net Profit
$41,795.60 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Thermo Fisher Scientific (TMO)
| -18.45 | -18.40 | -26.20 | -26.52 | -8.91 | 5.24 | 12.55 |
|
BSE Sensex*
| 2.52 | 3.37 | 6.44 | 8.80 | 12.18 | 20.37 | 11.43 |
|
S&P 100
| -7.84 | -4.23 | -10.10 | 11.63 | 11.27 | 15.45 | 11.18 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Thermo Fisher Scientific (TMO)
| -1.97 | -3.61 | -17.47 | 43.54 | 43.72 | 45.55 | 18.10 |
|
S&P 100
| 29.04 | 30.83 | -22.12 | 27.55 | 19.30 | 29.47 | -5.82 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 101.90 | 150,717.24 | 74.38 | 19.68 | |
| 197.14 | 141,087.18 | 38.13 | 7.37 | |
| 514.59 | 184,438.33 | 75.23 | 15.04 | |
| 235.88 | 34,618.69 | 26.44 | 24.45 |
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences... Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts. Read more
Chairman, President & CEO
Mr. Marc N. Casper
Chairman, President & CEO
Mr. Marc N. Casper
Headquarters
Waltham, MA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Thermo Fisher Scientific Inc (TMO) stood at $ 122,419 Mln as on 31-Mar-25
The share price of Thermo Fisher Scientific Inc (TMO) is $424.24 (NYSE) as of 25-Apr-2025 16:05 EDT. Thermo Fisher Scientific Inc (TMO) has given a return of -8.91% in the last 3 years.
Thermo Fisher Scientific Inc (TMO) has a market capitalisation of $ 161,061 Mln as on 25-Apr-2025. As per Value Research classification, it is a Large Cap company.
The P/B ratio of Thermo Fisher Scientific Inc (TMO) is 3.24 times as on 25-Apr-2025, a 10% discount to its peers’ median range of 3.59 times.
The P/E ratio of Thermo Fisher Scientific Inc (TMO) is 24.88 times as on 25-Apr-2025, a 72% discount to its peers’ median range of 87.38 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Thermo Fisher Scientific Inc (TMO) and enter the required number of quantities and click on buy to purchase the shares of Thermo Fisher Scientific Inc (TMO).
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
The CEO & director of Mr. Marc N. Casper. is Thermo Fisher Scientific Inc (TMO), and CFO & Sr. VP is Mr. Marc N. Casper.
There is no promoter pledging in Thermo Fisher Scientific Inc (TMO).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
17,481
|
|
|
14,631
|
|
|
14,049
|
|
|
3,149
|
| Thermo Fisher Scientific Inc (TMO) | Ratios |
|---|---|
|
Return on equity(%)
|
13.25
|
|
Operating margin(%)
|
18.48
|
|
Net Margin(%)
|
15.19
|
|
Dividend yield(%)
|
0.41
|
No, TTM profit after tax of Thermo Fisher Scientific Inc (TMO) was $0 Mln.
$-2.42
(
